COVID-19 Antibody Testing Moves Center-Stage In Germany With Major Input From Roche
Roche Diagnostics is promising a €400m investment at the site in Bavaria that has developed its new COVID-19 antibody test kits, three million of which will be delivered to German health care professionals in May.
You may also be interested in...
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
The company says the serology test has a specificity of 99.8% and sensitivity of 100%
The COVID-19 antibody tests that so far have gone through the validation process have not proven accurate enough to be rolled out for public use, says the UK. A new rapid test consortium is working on a solution.